Last checked at 11 Mar 2014 07:00
Avacta Group plc
("Avacta" or the "Group")
Notice of Interim Results
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, will announce its Interim Results, for the six month period ended 31 January 2014, on Wednesday 23rd April 2014.
An analyst briefing given by Alastair Smith, Chief Executive Officer, Craig Slater, Chief Operating Officer and Tim Sykes, Chief Financial Officer will be held at 9.30am on the day at a central location in the City of London to be confirmed. Analysts who wish to attend should contact Lianne Cawthorne on +44(0)20 7933 8788 or email avacta@walbrookpr.com to register.
Enquiries:
Avacta Group plc | Tel: +44 (0) 844 414 0452 | |
Alastair Smith, Chief Executive Officer | www.avacta.com | |
Tim Sykes, Chief Financial Officer | ||
Numis Securities Limited | Tel: +44 (0) 207 260 1000 | |
Michael Meade / Freddie Barnfield - Nominated Adviser | www.numiscorp.com | |
James Black - Corporate Broking | ||
Walbrook PR Ltd | Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com | |
Anna Dunphy | Mob: +44 (0)7876 741 001 | |
Lianne Cawthorne | Mob: +44 (0)7584 391 303 | |
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
Avacta Analytical www.avactaanalytical.com
| High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
Avacta Animal Health www.avactaanimalhealth.com
| Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod. |
Avacta Life Sciences www.avactalifesciences.com
| Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
Avacta joined AIM in August 2006 and is based in Wetherby, England.